Reviewing the Approval Process of Teclistamab in Multiple Myeloma
A group of experts discussed the approval process for teclistamab use in patients with multiple myeloma.
Defining a Space for NRG1 Fusion–Positive Tumors in Lung and GI Cancers
An overview of NRG1 fusion–positive tumors was given by experts in the gastrointestinal and lung cancer space in a recent Frontline Forum.
Patient's Perspective on Pembrolizumab/Lenvatinib Use in RCC
Thomas Hutson, DO, PharmD, meets with his patient Cesar Fuentes to discuss his diagnosis and treatment for renal cell carcinoma.
